Knight Therapeutics Inc.

Acting for Knight Therapeutics Inc. in its transformative acquisition of all of the issued and outstanding shares of Biotoscana Investments S.A. (GBT), a Luxembourg company listed on the Brazilian stock exchange, for an expected aggregate purchase price of $369 million.

Knight Therapeutics

Acted for Knight Therapeutics Inc. in successfully defending against the activist campaign, proxy contest and contested meeting led by Medison Biotech Ltd. with respect to Knight's 2019 annual meeting.

RELX Group plc

Acted for an affiliate of Elsevier, part of the RELX Group, a global provider of information and analytics for professional and business customers across industries, in its acquisition of Science-Metrix Inc., which specializes in research evaluation and bibliometric analysis.

Plusgrade L.P.

Acted for Plusgrade L.P. and its partners in the $200-million equity investment by Caisse de dépôt et placement du Québec. Plusgrade is a leading provider of revenue solutions to the travel industry, such as seat upgrades and other premium services, through its proprietary software platform.

Stingray Group Inc.

Acted for Stingray Group Inc. in its acquisition of DJ-Matic, a provider of in-store media solutions (music, video, digital signage) for businesses with clients in Belgium, the Netherlands, Germany and Denmark.

Stingray Group Inc.

Acted for Stingray Group Inc. in its $506-million acquisition of Newfoundland Capital Corporation Limited, one of Canada's leading radio broadcasters with 101 licences (82 FM and 19 AM) across Canada, and the financing of this acquisition, which included $450 million of new credit facilities and $138 million of equity, comprising a $83-million bought deal offering of subscription receipts, a $40-million private placement of subscription receipts to the Caisse de dépôt et placement du Québec, and $15 million from the exercise of pre-emption rights from the Boyko Group.

MacKinnon, Bennett & Co

Acted for MKB Partners Fund, Limited Partnership in connection with additional subscriptions and final close of fund, with commitments in excess of $50 million.

Neovia Probiotics Inc.

Acted for Neovia Probiotics Inc., an indirect subsidiary of a leading French agricultural cooperative group, in its acquisition (by way of a plan of arrangement) of Epicore BioNetworks Inc., a TSXV-listed company specializing in the sale of environmental biological products and specialty feeds.

Meyer Housewares Canada Inc.

Acted for Meyer Housewares Canada Inc. in connection with its acquisition from Canadian Tire Corporation, Limited, of the Padinox business in Prince Edward Island, which manufactures and distributes kitchenware.

KIK Custom Products Inc.

Acted for KIK Custom Products Inc. in its acquisition of Lavo Inc., a leading manufacturer and marketer of laundry detergent, household cleaners, fabric softeners and bleach in Canada.

Valtech S.E.

Acted for Valtech in its acquisition of all the outstanding shares of Non-Linear Creations Inc., a multinational digital services company with headquarters in Toronto as well as offices in Brazil and the United Kingdom.

Stingray Group Inc.

Acted for Stingray Group Inc. in connection with its acquisition of all the outstanding shares of C Music Entertainment Ltd. (also known as C Music TV).

Sweet Park Holdings Inc.

Acted for The Bensadoun Family Foundation, a principal shareholder of Aritzia Inc., in connection with Aritzia Inc.'s secondary offering of 20,100 million subordinate voting shares at a price of $17.45 per share, for aggregate gross proceeds of $350,745 million, sold via an investment vehicle managed by Berkshire Partners LLC.

Stingray Group Inc.

Acted for Stingray Group Inc. in connection with its acquisition of all the outstanding shares of Yokee Music Ltd.

Knight Therapeutics Inc.

Acted for Knight Therapeutics Inc. in connection with its $87-million bought deal of common shares and the exercise of the over-allotment option to purchase an additional $13-million worth of common shares.

MacKinnon, Bennett & Company Inc.

Acted for MKB Partners Fund in connection with its investment, together with Automobiles Peugeot, in Communauto Inc., one of the largest car-sharing services in the world.

Group of Leading Financial Institutions

Acted for a group of leading financial institutions in connection with the $1.25-billion refinancing for Air Canada. The group included TD Securities Inc., as representative of the initial purchasers of $200-million of Air Canada's 4.75% senior secured notes due 2023, and JPMorgan Chase Bank, N.A., as administrative agent and lender under a new US$1.1-billion senior secured credit facility.

itravel2000

Acted for itravel2000 in the sale of its retail travel business to Red Label Holdings Inc. parent company of TravelBrands and Redtag.ca

Stingray Group Inc.

Acting for Stingray Group Inc. in its acquisition of the Much television channels known as MuchVibe, MuchRetro, MuchLoud and Juicebox from Bell Media Inc.

Knight Therapeutics Inc.

Acted for Knight Therapeutics Inc. in connection with its $200-million bought deal offering of common shares and the exercise of the over-allotment option to purchase an additional $30-million worth of common shares.

Stingray Group Inc.

Acted for Stingray Group Inc. in connection with its acquisition of Nümedia, which provides intelligent media solutions to its clients, including enabling in-venue music.

Knight Therapeutics Inc.

Acted for Knight Therapeutics Inc. in connection with the entering into a distribution, license and supply agreement with Profound Medical Inc.

Stingray Group Inc.

Acted for Stingray Group Inc. in connection with the acquisition of Digital Music Distribution Pty. Ltd. (DMD), Australia's most important digital music services provider.

First Quality Enterprises, Inc.

Acted as Canadian counsel to First Quality Enterprises, Inc., and its affiliates in connection with the acquisition of Fempro I Inc. and related companies.

Stingray Group Inc.

Acted for Stingray Group Inc. in connection with its acquisition of all of the issued and outstanding shares in the share capital of Brava NL BV, Brava HDTV and Djazz TV BV, distributors of three successful thematic channels dedicated to high-end music and cultural content distributed to an estimated 35 million subscribers in 50 countries.

Stingray Group Inc.

Acted for Stingray Group Inc. in connection with its initial public offering on the Toronto Stock Exchange (TSX) of an aggregate of 25,760,000 subordinate voting shares and variable subordinate voting shares at a price of $6.25 per share, for total gross proceeds of $161 million (including the exercise in full of the over-allotment option granted to the underwriters).

Stingray Digital Media Inc.

Acted for Stingray Business in connection with the acquisition of all of the outstanding shares of Groupe Viva.

Logibec Inc.

Acted for the management team of Logibec Inc. in connection with the sale of Logibec Inc.'s shares to US private equity firm GI Partners. Logibec is a leading Canadian healthcare IT company specializing in the development, marketing, implementation and support of clinical and administrative information systems for the health and social services sectors.

Knight Therapeutics inc.

Acted for Knight Therapeutics Inc. in connection with its $87-million bought deal of common shares and the exercise of the over-allotment option to purchase an additional $13-million worth of common shares.

Knight Therapeutics Inc.

Acted for a wholly owned subsidiary of Knight Therapeutics Inc., in the US$125 million cash sale of its Neglected Tropical Disease Priority Review Voucher, which was granted by the U.S. Food and Drug Administration with the approval of Impavidor (miltefosine) for treatment of patients with visceral, mucosal and cutaneous leishmaniasis, to Gilead Sciences, Inc.

Knight Therapeutics Inc.

Acted for Knight Therapeutics Inc. in connection with its $180-million bought deal private placement of special warrants.

J.P. Morgan Securities Inc.

Acted for J.P. Morgan Securities Inc. as joint book runner and representative of the initial purchasers in connection with US$400-million unsecured notes of Air Canada.

Knight Therapeutics Inc.

Acting for Knight Therapeutics Inc. in connection with its $75-million bought deal private placement of special warrants.

Paladin Labs Inc.

Acted for Paladin Labs Inc. in connection with its acquisition by Endo Health Solutions Inc. in a stock and cash transaction valued at approximately $3 billion.

Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ and Investissement Québec

Acted for Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ and Investissement Québec, the Initial Limited Partners, in the formation and investment in Teralys Capital Fund of Funds, L.P., a $700-million Québec-based venture capital Fund of Funds.

Cycle Capital Management Inc.

Acted for Cycle Capital Management Inc. on the formation of its first $80-million investment fund devoted to the clean technology and renewable energy sector, Cycle Capital Fund I, L.P.

AbitibiBowater Inc.

Acted for AbitibiBowater Inc. (now known as Resolute Forest Products) in connection with the sale of its Snowflake, Arizona mill to Catalyst Paper Corporation in a transaction valued at US$161 million.

Abitibi-Consolidated Inc.

Acted for Abitibi-Consolidated Inc. (now known as Resolute Forest Products) in connection with its merger of equals with Bowater Incorporated to create a company with a combined enterprise value of US$8 billion.